Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -910 | -266 | -1,040 | -829 | -681 |
| Depreciation Amortization | 7 | 7 | 7 | 5 | 1 |
| Accounts receivable | N/A | -13 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -11 | N/A | -16 | N/A |
| Other Working Capital | 96 | 61 | -17 | -28 | 332 |
| Other Operating Activity | 581 | 54 | 507 | 534 | 163 |
| Operating Cash Flow | $-226 | $-169 | $-544 | $-334 | $-186 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22 | -5 | -4 | N/A | -22 |
| Net Acquisitions | -80 | -75 | -80 | N/A | N/A |
| Investing Cash Flow | $-103 | $-80 | $-84 | $N/A | $-22 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 12 | 25 | 24 | 9 |
| Debt Issued | 394 | 369 | 697 | 404 | 188 |
| Debt Repayment | -146 | -131 | -115 | -50 | N/A |
| Common Stock Issued | N/A | N/A | 64 | 64 | 64 |
| Other Financing Activity | 15 | -1 | 0 | 14 | 14 |
| Financing Cash Flow | $263 | $249 | $671 | $457 | $276 |
| Exchange Rate Effect | -6 | -3 | 7 | 8 | 4 |
| Beginning Cash Position | 108 | 108 | 58 | 58 | 58 |
| End Cash Position | 36 | 105 | 108 | 188 | 129 |
| Net Cash Flow | $-71 | $0 | $43 | $131 | $68 |
| Free Cash Flow | |||||
| Operating Cash Flow | -226 | -169 | -544 | -334 | -186 |
| Capital Expenditure | -22 | -5 | -4 | N/A | -22 |
| Free Cash Flow | -248 | -173 | -547 | -334 | -208 |